EW – Edwards Lifesciences Corp. – Fundamental analysis, financial statements, key ratios, and fair value analysis

Edwards Lifesciences Corp.

Healthcare
Medical Devices
148.72
5.06
3.52%
174.1
118.14
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)3.32
EPS Estimate Currrent Qtr1.17
Book Value Per Share16.08
Market Cap 31 Billion
PE Ratio 42
Dividend YieldNA

Stock Yield

Stock Return 7 Days7.50%
Stock Return 15 Days-2.97%
Stock Return 30 Days -7.97%
Stock Return 3 Months-7.21%
Stock Return One Year34.80%
Stock Return 3 Years37.27%

Stock Technical Analysis

Relative Strengh Index (14)30.39
Average True Range (14)5.61
Momentum (14)-19.48
Simple Moving Average (14) -19.48
Time Series Forecast (14)143.69
Time Series Forecast (30) 163.56

Stock News

Financial Statements

index2014201520162017
Revenue2 Billion2 Billion3 Billion3 Billion
Cost of Revenue626 Million617 Million797 Million875 Million
Gross Profit2 Billion2 Billion2 Billion3 Billion
Gross Margin (%)73.07%75.25%73.09%74.52%
Selling General and Administrative Expense858 Million851 Million905 Million985 Million
Other operating expenses-322 Million386 Million504 Million517 Million
Earning Before Interest and Taxes EBIT1 Billion640 Million757 Million1 Billion
EBIT/Operating Margin (%)49.99%25.65%25.55%30.80%
Interest Expense17 Million17 Million19 Million23 Million
Other non-operating expenses/income0000
Earnings before Tax1 Billion622 Million738 Million1 Billion
Income Tax Expense333 Million128 Million168 Million451 Million
Net Income811 Million495 Million570 Million584 Million
Net Margin (%)34.92%19.85%19.22%16.99%
Earnings per share from operating income0.382790.5743920.5093530.671503
Earnings per Diluted Share3.742.252.612.7
Dividends per Basic Common Share0000
Weighted average number of shares outstanding217 Million220 Million218 Million216 Million
index2017 Q42018 Q12018 Q22018 Q3
Revenue888 Million895 Million944 Million907 Million
Cost of Revenue235 Million234 Million246 Million225 Million
Gross Profit653 Million661 Million698 Million682 Million
Gross Margin (%)73.52%73.89%73.91%75.19%
Selling General and Administrative Expense267 Million256 Million275 Million270 Million
Other operating expenses43 Million142 Million172 Million163 Million
Earning Before Interest and Taxes EBIT343 Million263 Million251 Million249 Million
EBIT/Operating Margin (%)38.63%29.36%26.60%27.49%
Interest Expense19 Million-800 Thousand0500 Thousand
Other non-operating expenses/income0000
Earnings before Tax324 Million264 Million251 Million249 Million
Income Tax Expense327 Million57 Million-32 Million23 Million
Net Income-3 Million207 Million283 Million226 Million
Net Margin (%)-0.00%23.09%29.96%24.92%
Earnings per share from operating income12 Thousand1.324520.6726271.0407
Earnings per Diluted Share-00.961.321.06
Dividends per Basic Common Share0000
Weighted average number of shares outstanding280 Million215 Million214 Million213 Million
index2014201520162017
Cash and Equivalents654 Million718 Million930 Million818 Million
Trade and Non Trade Receivables331 Million372 Million415 Million479 Million
Inventory297 Million340 Million397 Million555 Million
Other current assets2 Billion2 Billion2 Billion2 Billion
Current Assets2 Billion2 Billion2 Billion3 Billion
Total Non-Current Assets1 Billion2 Billion2 Billion3 Billion
Total Assets4 Billion4 Billion5 Billion6 Billion
Trade and Non Trade Payables426 Million476 Million532 Million770 Million
Other current liabilities000650 Million
Current Liabilities426 Million476 Million532 Million1 Billion
Liabilities Non Current906 Million1 Billion1 Billion1 Billion
Accumulated Retained Earnings Deficit3 Billion3 Billion4 Billion2 Billion
Shareholder’s equity other-650 Million-834 Million-1 Billion994 Million
Shareholders Equity2 Billion3 Billion3 Billion3 Billion
Noncontrolling interests852 Million952 Million1 Billion3 Billion
Total Assets4 Billion4 Billion5 Billion6 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents818 Million1 Billion1 Billion1 Billion
Trade and Non Trade Receivables479 Million447 Million520 Million530 Million
Inventory555 Million574 Million568 Million584 Million
Other current assets2 Billion3 Billion3 Billion3 Billion
Current Assets3 Billion3 Billion3 Billion3 Billion
Total Non-Current Assets3 Billion3 Billion3 Billion3 Billion
Total Assets6 Billion6 Billion6 Billion6 Billion
Trade and Non Trade Payables770 Million674 Million584 Million661 Million
Other current liabilities650 Million640 Million599 Million600 Million
Current Liabilities1 Billion1 Billion1 Billion1 Billion
Liabilities Non Current1 Billion1 Billion1 Billion1 Billion
Accumulated Retained Earnings Deficit2 Billion2 Billion2 Billion3 Billion
Shareholder’s equity other994 Million1 Billion702 Million674 Million
Shareholders Equity3 Billion3 Billion3 Billion3 Billion
Noncontrolling interests3 Billion3 Billion2 Billion3 Billion
Total Assets6 Billion6 Billion6 Billion6 Billion
index2014201520162017
Net Cash Flow from Operations1 Billion550 Million704 Million1 Billion
Capital Expenditure-83 Million-103 Million-176 Million-168 Million
Net Cash Flow from Investing-633 Million-316 Million-212 Million-647 Million
Net Cash Flow from Financing-153 Million-159 Million-268 Million-473 Million
Cash and Equivalents654 Million718 Million930 Million818 Million
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations364 Million151 Million140 Million342 Million
Capital Expenditure-52 Million-43 Million-53 Million-85 Million
Net Cash Flow from Investing49 Million220 Million105 Million-254 Million
Net Cash Flow from Financing-229 Million41 Million-241 Million-57 Million
Cash and Equivalents818 Million1 Billion1 Billion1 Billion

Stock Price History

table